首页> 美国卫生研究院文献>other >Five Active Components Compatibility of Astragali Radix and Angelicae Sinensis Radix Protect Hematopoietic Function Against Cyclophosphamide-Induced Injury in Mice and t-BHP–Induced Injury in HSCs
【2h】

Five Active Components Compatibility of Astragali Radix and Angelicae Sinensis Radix Protect Hematopoietic Function Against Cyclophosphamide-Induced Injury in Mice and t-BHP–Induced Injury in HSCs

机译:黄芪和当归的五种有效成分的相容性可以保护造血功能抵抗环磷酰胺对小鼠的伤害和t-BHP诱导的HSC伤害

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although the compatibility of Astragali Radix (AR) and Angelicae Sinensis Radix (ASR) has favorable effect on promoting hematopoiesis in traditional Chinese medicine (TCM), the main active components and pharmacological mechanism are unknown. We investigated the five active components and its mechanisms in vitro and in vivo. Five active components of Astragalus glycosides (AST), Formononetin (FRM), Ferulic acid (FRA), Calycosin (CAL), and Calycosin-7-glucoside (CLG), which could be absorbed in intestinal tract, were detected in this study. The peripheral blood, hematopoietic growth factors (HGFs), and hematopoietic progenitor cells (HPCs) colony were observed to evaluate the effect of these five active components promoting hematopoiesis. Furthermore, hematopoietic stem cell (HSC) proliferation, aging, cycle, and related proteins were detected to explore the mechanism of these five components promoting HSC proliferation. >i) The in vivo experiments showed that the combination of the five active components could remarkably increase the number of RBCs, WBCs, PLTs, and content of Hb in peripheral blood and the area of bone marrow hematopoietic tissue, as well as thrombopoietin (TPO), erythropoietin (EPO), granulocyte-macrophage colony stimulating factor (GM-CSF), and colony of CFU-GM, CFU-MK, CFU-E, and BFU-E in serum. Each of these five components promoted the recovery of RBCs and Hb, and increased TPO, CFU-MK, and CFU-E. All components except for AST increased the CFU-GM. FRA increased the number of WBCs, the area of bone marrow hematopoietic tissue, and BFU-E. FRA and AST promoted PLT recovery. FRA and CAL improved the content of GM-CSF. FRA, CAL, and CLG improved the content of EPO. >ii) The in vitro experiments showed that FRA, FRM, and AST significantly promoted cell proliferation, reduced the positive rate and G0/G1 cells, and increased G2/M + S cells and the expression of cyclin D1 and CDK4 proteins in aging HSCs. Furthermore, the combination of five components had the best effect. Taken together, the five active components of AST, FRM, FRA, CAL, and CLG were the main pharmacodynamic substances of the AR-ASR compatibility, which promoted hematopoiesis. The combination of them had a synergistic effect. The mechanism of promoting hematopoiesis may be relevant to regulating cyclin-related proteins, promoting cell cycle transformation, and promoting HSC proliferation.
机译:尽管黄芪和当归的配伍对中药造血作用有很好的促进作用,但其主要活性成分和药理机制尚不清楚。我们在体外和体内研究了五个活性成分及其机制。在本研究中,检测到可被肠道吸收的黄芪糖苷(AST),Formononetin(FRM),阿魏酸(FRA),Calycosin(CAL)和Calycosin-7-葡萄糖苷(CLG)的五个活性成分。观察外周血,造血生长因子(HGF)和造血祖细胞(HPC)集落,以评估这五个促进造血作用的活性成分的作用。此外,还检测了造血干细胞(HSC)的增殖,衰老,周期和相关蛋白,以探索这五个成分促进HSC增殖的机制。 > i)体内实验表明,五种活性成分的组合可显着增加外周血和骨髓造血组织中RBC,WBC,PLT和Hb的含量,以及血清中的血小板生成素(TPO),促红细胞生成素(EPO),粒细胞巨噬细胞集落刺激因子(GM-CSF)和CFU-GM,CFU-MK,CFU-E和BFU-E的集落。这五种成分均促进了RBC和Hb的恢复,并增加了TPO,CFU-MK和CFU-E。除AST以外的所有组件均增加了CFU-GM。 FRA增加了白细胞的数量,骨髓造血组织的面积和BFU-E。 FRA和AST促进了PLT的恢复。 FRA和CAL改善了GM-CSF的含量。 FRA,CAL和CLG改善了EPO的含量。 > ii)体外实验表明,FRA,FRM和AST显着促进细胞增殖,降低阳性率和G0 / G1细胞,并增加G2 / M + S细胞和细胞周期蛋白D1的表达和HSKs中的CDK4蛋白。此外,五种成分的组合效果最佳。综上所述,AST,FRM,FRA,CAL和CLG的五个活性成分是AR-ASR相容性的主要药效学物质,可促进造血作用。它们的组合具有协同作用。促进造血作用的机制可能与调节细胞周期蛋白相关蛋白,促进细胞周期转化和促进HSC增殖有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号